Background: Acute humoral rejection (AHR) is the most important risk factor for early graft loss in ABO-incompatible (ABO-i) kidney transplantation (RTx). The pathogenesis and diagnostic criteria for AHR after ABO-i RTx remain unclear. Complement fragment C4d deposition in peritubular capillaries (PTC), which is a sensitive indicator for activation of the classical complement pathway, was studied to establish the pathologic diagnostic indicator of AHR.
Methods: Forty-four graft biopsy specimens from 19 patients with ABO-i living donors were analyzed within 90 days after RTx. Nineteen biopsy specimens with acute rejection after ABO-compatible (ABO-c) living-related RTx were used as controls. Diffuse and bright C4d deposition in PTC was considered significantly positive.
Results: All of 8 recipients with AHR showed significantly positive C4d in PTC in the ABO-i group, but 9 of 11 recipients without AHR were negative. In the ABO-c RTx group, 16 of 19 recipients were negative for C4d in PTC. The prevalence of C4d in PTC was significantly higher in ABO-i RTx (P<0.05).
Conclusions: C4d deposition is valuable as a specific and sensitive indicator for AHR, even of mild severity, in ABO-i RTx.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.TP.0000053402.87256.6B | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study.
Am J Transplant
November 2024
Immune Tolerance Network, Seattle, Washington, USA. Electronic address:
Immunosuppression can be withdrawn from selected liver transplant recipients, although robust clinical predictors of tolerance remain elusive. The Immune Tolerance Network ITN056ST study (OPTIMAL; NCT02533180) assessed clinical outcomes and mechanistic correlates of phased immunosuppression withdrawal (ISW) in nonautoimmune, nonviral adult liver transplant recipients. Enrolled subjects were ≥3 years posttransplant with minimal/absent inflammation or fibrosis on a screening liver biopsy.
View Article and Find Full Text PDFThe prognostic role of activation of the complement pathways in the progression of advanced IgA nephropathy to end-stage renal disease.
BMC Nephrol
October 2024
Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, 100029, China.
Introduction: The role of complement system in late stage of IgA nephropathy (IgAN) remains unknown. We therefore investigated the effects of complement system on worsening kidney function in advanced (stage 4 CKD) IgAN.
Methods: Renal specimens of 69 IgAN patients who underwent renal biopsy during stage 4 CKD between 2010 and 2021, were stained using immunofluorescence (IF) and immunohistochemistry (IHC) for glomerular complement components.
Recent status and trends of innate immunity and the gut-kidney aixs in IgAN: A systematic review and bibliometric analysis.
Int Immunopharmacol
December 2024
School of Clinical Medicine, Chengdu Medical College, Chengdu 610500, China; Department of Nephrology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China. Electronic address:
Article Synopsis
- There is a growing global focus on understanding and treating IgA nephropathy (IgAN), particularly how innate immunity and the complement system play a key role in its development, alongside the important gut-kidney axis pathway.
- A comprehensive literature review from 2000 to 2023 revealed 720 publications on IgAN, with 436 being highly relevant; research indicates an increasing interest, especially from the United States, which leads in publication impact.
- Recent studies emphasize the interplay between IgAN and innate immunity, highlighting the gut-kidney axis's influence, indicating that understanding these relationships is essential for improving prevention, diagnosis, and treatment strategies.
Accurate Visualization of C4d Complement Fragment in Immunohistochemistry by C-Terminal Linear Neoepitope-Specific Antibodies.
Int J Mol Sci
September 2024
Department of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211 Gdańsk, Poland.
Article Synopsis
- * The reactive thioester group in C4d allows it to label nearby surfaces, making it useful for immunohistochemical staining, though there are concerns about the reliability due to high background signals in tissues.
- * An improved rabbit anti-C4d antibody has been developed, showing less cross-reactivity and better performance in staining kidney transplant biopsies compared to existing antibodies, enhancing its diagnostic accuracy.
Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B.
Antiviral Res
November 2024
Shanghai Public Health Clinical Centre, Fudan University, Shanghai, China; Faculty of Science and Technology, University of Canberra, Australia. Electronic address:
Article Synopsis
- Chronic infection with Hepatitis B Virus (HBV) leads to weak virus-specific T cell responses, complicating viral clearance while causing significant liver inflammation due to immune responses.
- A new assay developed for detecting HBV Capsid-Antibody Complexes (CACs) showed high accuracy in measuring these complexes in serum and linked them to increased liver inflammation and damage in chronic hepatitis B patients.
- The study provides strong evidence that CACs play a key role in complement-mediated liver injury, establishing a new factor to consider alongside existing clinical markers for monitoring inflammation in chronic hepatitis B.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!